We believe that there are huge opportunities for both companies to grow in DVT (by displacing other treatments), and Inari, in particular, has even bigger opportunities in PE (which it dominates ...

Shares of Inari Medical, Inc. (NASDAQ:NARI – Get Free Report) have been given an average rating of “Hold” by the fourteen brokerages that are currently covering the stock, MarketBeat reports. Twelve ...

The company has a market capitalization of $4.68 billion, a PE ratio of -59.24 and a beta of 1.02. Inari Medical, Inc. has a 1-year low of $36.73 and a 1-year high of $79.99. NARI has been the ...

PORTAGE, Mich., March 6, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System.